42 related articles for article (PubMed ID: 27354603)
1. The role of interleukin-8 (IL-8) and IL-8 receptors in platinum response in high grade serous ovarian carcinoma.
Stronach EA; Cunnea P; Turner C; Guney T; Aiyappa R; Jeyapalan S; de Sousa CH; Browne A; Magdy N; Studd JB; Sriraksa R; Gabra H; El-Bahrawy M
Oncotarget; 2015 Oct; 6(31):31593-603. PubMed ID: 26267317
[TBL] [Abstract][Full Text] [Related]
2. CCNE1 expression in high grade serous carcinoma does not correlate with chemoresistance.
Sapoznik S; Aviel-Ronen S; Bahar-Shany K; Zadok O; Levanon K
Oncotarget; 2017 Sep; 8(37):62240-62247. PubMed ID: 28977941
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Chemoresistance in Ovarian Cancer: Emerging Hallmarks, Signaling Mechanisms and Alternative Pathways.
Zaib S; Javed H; Rana N; Zaib Z; Iqbal S; Khan I
Curr Med Chem; 2024 Jan; ():. PubMed ID: 38275065
[TBL] [Abstract][Full Text] [Related]
4. A Proteomic Investigation to Discover Candidate Proteins Involved in Novel Mechanisms of 5-Fluorouracil Resistance in Colorectal Cancer.
Ortega Duran M; Shaheed SU; Sutton CW; Shnyder SD
Cells; 2024 Feb; 13(4):. PubMed ID: 38391955
[TBL] [Abstract][Full Text] [Related]
5. Endometriosis Stem Cells as a Possible Main Target for Carcinogenesis of Endometriosis-Associated Ovarian Cancer (EAOC).
Wilczyński JR; Szubert M; Paradowska E; Wilczyński M
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612107
[TBL] [Abstract][Full Text] [Related]
6. Role of NRF2 in Ovarian Cancer.
Tossetta G; Fantone S; Montanari E; Marzioni D; Goteri G
Antioxidants (Basel); 2022 Mar; 11(4):. PubMed ID: 35453348
[TBL] [Abstract][Full Text] [Related]
7. Cancer Stem Cells in Ovarian Cancer-A Source of Tumor Success and a Challenging Target for Novel Therapies.
Wilczyński JR; Wilczyński M; Paradowska E
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269636
[TBL] [Abstract][Full Text] [Related]
8. Revisiting therapeutic strategies for ovarian cancer by focusing on redox homeostasis.
Kobayashi H; Imanaka S; Shigetomi H
Oncol Lett; 2022 Mar; 23(3):80. PubMed ID: 35111249
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Targeting of Signaling Pathways Related to Cancer Stemness.
Espinosa-Sánchez A; Suárez-Martínez E; Sánchez-Díaz L; Carnero A
Front Oncol; 2020; 10():1533. PubMed ID: 32984007
[TBL] [Abstract][Full Text] [Related]
10. Overcoming cisplatin resistance by targeting the MTDH-PTEN interaction in ovarian cancer with sera derived from rats exposed to Guizhi Fuling wan extract.
Han L; Cao X; Chen Z; Guo X; Yang L; Zhou Y; Bian H
BMC Complement Med Ther; 2020 Feb; 20(1):57. PubMed ID: 32066429
[TBL] [Abstract][Full Text] [Related]
11. Chrysin and Docetaxel Loaded Biodegradable Micelle for Combination Chemotherapy of Cancer Stem Cell.
Ghamkhari A; Pouyafar A; Salehi R; Rahbarghazi R
Pharm Res; 2019 Oct; 36(12):165. PubMed ID: 31646391
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the benefits of neoadjuvant chemotherapy for advanced epithelial ovarian cancer: a retrospective study.
Gao Y; Li Y; Zhang C; Han J; Liang H; Zhang K; Guo H
J Ovarian Res; 2019 Sep; 12(1):85. PubMed ID: 31519183
[TBL] [Abstract][Full Text] [Related]
13. New markers for human ovarian cancer that link platinum resistance to the cancer stem cell phenotype and define new therapeutic combinations and diagnostic tools.
Muñoz-Galván S; Felipe-Abrio B; García-Carrasco M; Domínguez-Piñol J; Suarez-Martinez E; Verdugo-Sivianes EM; Espinosa-Sánchez A; Navas LE; Otero-Albiol D; Marin JJ; Jiménez-García MP; García-Heredia JM; Quiroga AG; Estevez-Garcia P; Carnero A
J Exp Clin Cancer Res; 2019 Jun; 38(1):234. PubMed ID: 31159852
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of E74-Like Factor 5 (ELF5) Inhibits Migration and Invasion of Ovarian Cancer Cells.
Zhang X; Lin J; Ma Y; Zhao J
Med Sci Monit; 2019 Jan; 25():856-865. PubMed ID: 30696803
[TBL] [Abstract][Full Text] [Related]
15. The Role of Redox-Regulating Enzymes in Inoperable Breast Cancers Treated with Neoadjuvant Chemotherapy.
Roininen N; Haapasaari KM; Karihtala P
Oxid Med Cell Longev; 2017; 2017():2908039. PubMed ID: 29348788
[TBL] [Abstract][Full Text] [Related]
16. Identification of DJ-1 as a contributor to multidrug resistance in human small-cell lung cancer using proteomic analysis.
Gao H; Niu Y; Li M; Fang S; Guo L
Int J Exp Pathol; 2017 Apr; 98(2):67-74. PubMed ID: 28580701
[TBL] [Abstract][Full Text] [Related]
17. Cancer Stem Cell Properties as Factors Predictive of Chemoresistance in Neoadjuvantly-treated Patients with Ovarian Cancer.
Pylväs-Eerola M; Liakka A; Puistola U; Koivunen J; Karihtala P
Anticancer Res; 2016 Jul; 36(7):3425-31. PubMed ID: 27354603
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of ALDH1-positive cells after neoadjuvant chemotherapy predicts treatment resistance and prognosticates poor outcome in ovarian cancer.
Ayub TH; Keyver-Paik MD; Debald M; Rostamzadeh B; Thiesler T; Schröder L; Barchet W; Abramian A; Kaiser C; Kristiansen G; Kuhn W; Kübler K
Oncotarget; 2015 Jun; 6(18):16437-48. PubMed ID: 25999351
[TBL] [Abstract][Full Text] [Related]
19. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.
Tanei T; Morimoto K; Shimazu K; Kim SJ; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2009 Jun; 15(12):4234-41. PubMed ID: 19509181
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
